Privia Health Group, Inc. (NASDAQ:PRVA) CEO Sells $2,500,127.00 in Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Privia Health Group Stock Performance

NASDAQ:PRVA traded up $0.58 during trading on Thursday, reaching $18.84. The company’s stock had a trading volume of 1,241,269 shares, compared to its average volume of 878,641. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $25.92. The firm has a market cap of $2.25 billion, a price-to-earnings ratio of 121.73, a price-to-earnings-growth ratio of 4.36 and a beta of 0.78. The firm has a 50 day moving average of $19.32 and a 200-day moving average of $18.81.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.02). The company had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. Privia Health Group’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.06 EPS. Equities research analysts forecast that Privia Health Group, Inc. will post 0.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in Privia Health Group by 1.1% in the first quarter. Vanguard Group Inc. now owns 11,400,035 shares of the company’s stock valued at $223,327,000 after purchasing an additional 121,701 shares during the last quarter. Riverbridge Partners LLC raised its stake in shares of Privia Health Group by 17.5% in the first quarter. Riverbridge Partners LLC now owns 5,399,662 shares of the company’s stock valued at $105,779,000 after buying an additional 804,304 shares during the period. Norges Bank purchased a new position in shares of Privia Health Group during the 4th quarter valued at $27,959,000. Millennium Management LLC grew its stake in shares of Privia Health Group by 2,994.2% during the 2nd quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock worth $19,788,000 after acquiring an additional 1,101,730 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in Privia Health Group by 18.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock worth $19,441,000 after acquiring an additional 173,934 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on PRVA shares. Baird R W upgraded shares of Privia Health Group to a “strong-buy” rating in a research note on Thursday, May 30th. Evercore ISI decreased their target price on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Truist Financial dropped their price target on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. Robert W. Baird boosted their price objective on Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Finally, Barclays lowered their price objective on Privia Health Group from $22.00 to $19.00 and set an “equal weight” rating for the company in a research note on Monday, May 20th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus target price of $24.86.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.